{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:23Z","timestamp":1793600783309,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jid.2026.02.020","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:21:39Z","timestamp":1773249699000},"page":"2541-2553.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell proteomics reveal lesion-specific aberrant T cells and immunological profiles in mycosis fungoides"],"prefix":"10.1016","volume":"146","author":[{"given":"Eleni-Kyriaki","family":"Vetsika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Patentalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kyriakidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antreas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Koumourtzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Lampadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Marinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-1583","authenticated-orcid":false,"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.02.020_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5582581","article-title":"IL-31 and IL-8 in cutaneous T-cell lymphoma: looking for their role in itch","volume":"2021","author":"Abreu","year":"2021","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jid.2026.02.020_bib2","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/cells12151944","article-title":"A microenvironment-related nine-gene signature may predict survival in mycosis fungoides patients at diagnosis","volume":"12","author":"Alberti-Violetti","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.02.020_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102679","article-title":"Real-life efficacy of immunotherapy for S\u00e9zary syndrome: a multicenter observational cohort study","volume":"73","author":"Bozonnat","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.jid.2026.02.020_bib4","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/bloodadvances.2024014495","article-title":"Spatial transcriptomics of progression gene signature and tumor microenvironment leading to progression in mycosis fungoides","volume":"9","author":"Choi","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2026.02.020_bib5","doi-asserted-by":"crossref","first-page":"e1098","DOI":"10.1016\/j.clml.2025.08.008","article-title":"Skin response to mogamulizumab in patients with mycosis fungoides and Sezary syndrome: a retrospective, real world cohort","volume":"25","author":"Christensen","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jid.2026.02.020_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ijc.20373","article-title":"Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome)","volume":"112","author":"Cir\u00e9e","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2026.02.020_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bjd.21063","article-title":"Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and S\u00e9zary syndrome: association with disease stage and clinical outcome","volume":"187","author":"Di Raimondo","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers15030746","article-title":"Mycosis fungoides and S\u00e9zary syndrome: microenvironment and cancer progression","volume":"15","author":"Dobos","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2026.02.020_bib9","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/bloodadvances.2023012125","article-title":"Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression","volume":"8","author":"Fl\u00e9chon","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2026.02.020_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170015","article-title":"The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis","volume":"8","author":"Gaydosik","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2026.02.020_bib11","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1158\/1078-0432.CCR-05-1434","article-title":"Activation of neutrophils in cutaneous T-cell lymphoma","volume":"11","author":"Goddard","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2026.02.020_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/cells11071062","article-title":"Mass cytometric analysis of early-stage mycosis fungoides","volume":"11","author":"Guo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jid.2026.02.020_bib13","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood.2022017548","article-title":"Improved semiautomated detection of TRBC-restricted S\u00e9zary cells unveils a spectrum of clonal cluster immunophenotypes","volume":"140","author":"Horna","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.02.020_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/cyto.b.21878","article-title":"Flow cytometric evaluation of peripheral blood for suspected S\u00e9zary syndrome or mycosis fungoides: international guidelines for assay characteristics","volume":"100","author":"Horna","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jid.2026.02.020_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cyto.b.21963","article-title":"International guidelines for the flow cytometric evaluation of peripheral blood for suspected S\u00e9zary syndrome or mycosis fungoides: assay development\/optimization, validation, and ongoing quality monitors","volume":"100","author":"Illingworth","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jid.2026.02.020_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/dermatopathology9010009","article-title":"Polarization of macrophages in granulomatous cutaneous T cell lymphoma granulomatous mycosis fungoides microenvironment","volume":"9","author":"Johanny","year":"2022","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.jid.2026.02.020_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cup.14810","article-title":"Histopathologic evaluation of density and depth of the lymphoid infiltrate in clinically defined patches and plaques in early stage mycosis fungoides","volume":"52","author":"Kersten","year":"2025","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jid.2026.02.020_bib18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2026.02.020_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.2024024817","article-title":"Genetic alteration of class I HLA in cutaneous T-cell lymphoma","volume":"145","author":"Kwang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.02.020_bib20","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3390\/cancers16193368","article-title":"The tumor microenvironment as a therapeutic target in cutaneous T cell lymphoma","volume":"16","author":"Kwantwi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2026.02.020_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.02.020_bib22","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41590-024-02018-1","article-title":"Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment [published correction appears in Nat Immunol 2025;26:147]","volume":"25","author":"Li","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2026.02.020_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5021\/ad.2021.33.6.487","article-title":"The role of tumor microenvironment in mycosis fungoides and S\u00e9zary syndrome","volume":"33","author":"Liu","year":"2021","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cyto.b.21933","article-title":"Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides\/S\u00e9zary syndrome than quantification of CD26- or CD7- CD4+ T-cells","volume":"100","author":"Lyapichev","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jid.2026.02.020_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjd.21678","article-title":"TRBC1 expression assessed by flow cytometry as a novel marker of clonality in cutaneous \u03b1\u03b2 T-cell lymphomas with peripheral blood involvement","volume":"187","author":"Martin-Moro","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1182\/bloodadvances.2018025114","article-title":"Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR","volume":"3","author":"Murray","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2026.02.020_bib27","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3775","article-title":"Role of B-cells in mycosis fungoides","volume":"101","author":"Nielsen","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2026.02.020_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/10428194.2012.726720","article-title":"Vascular endothelial growth factor receptor-3 expression in mycosis fungoides","volume":"54","author":"Pedersen","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jid.2026.02.020_bib29","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-021-26974-6","article-title":"Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma","volume":"12","author":"Phillips","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2026.02.020_bib30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/bjh.20060","article-title":"The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphoma","volume":"206","author":"Pierog","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jid.2026.02.020_bib31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jdv.18852","article-title":"Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: an EORTC-CLTG\/ISCL survey","volume":"37","author":"Quaglino","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2026.02.020_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.humpath.2023.10.005","article-title":"Phenotypic switch in mycosis fungoides: a tertiary cancer center experience","volume":"142","author":"Ronen","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2026.02.020_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1346-8138.14033","article-title":"Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and S\u00e9zary syndrome","volume":"45","author":"Sakamoto","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cyto.a.22512","article-title":"Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin","volume":"85","author":"Sako","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.jid.2026.02.020_bib35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaad.2020.05.110","article-title":"Evaluation of the polymerase chain reaction-based T-cell receptor \u03b2 clonality test in the diagnosis of early mycosis fungoides","volume":"83","author":"Schachter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2340\/00015555-1220","article-title":"Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and S\u00e9zary syndrome","volume":"92","author":"Schwingshackl","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2026.02.020_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2340\/00015555-3207","article-title":"Expression of CCR3 and CCR4 suggests a poor prognosis in mycosis fungoides and S\u00e9zary syndrome","volume":"99","author":"Shono","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2026.02.020_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115484","article-title":"Phase II trial of atezolizumab (anti-PD-L1) in the treatment of relapsed\/refractory IIB\/IVB mycosis fungoides\/S\u00e9zary syndrome patients after previous systemic treatment. EORTC-1652-CLTG \u201cPARCT\u201d","volume":"222","author":"Stadler","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.02.020_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1346-8138.12852","article-title":"CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis","volume":"42","author":"Sugaya","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1684\/ejd.2014.2437","article-title":"Increase of DC-LAMP+ mature dendritic cell subsets in dermatopathic lymphadenitis of mycosis fungoides","volume":"24","author":"Tada","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2026.02.020_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930979","article-title":"Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: results of a pilot study","volume":"13","author":"Terhorst-Molawi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.02.020_bib42","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2026.02.020_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1474564","article-title":"The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.02.020_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2026.02.020_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403680","article-title":"Insufficient PD-1 expression during active autoimmune responses: a deep single-cell proteomics analysis in inflammatory arthritis","volume":"15","author":"Vetsika","year":"2024","journal-title":"Front Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26007517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26007517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:30:49Z","timestamp":1793597449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26007517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022202X26007517"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.02.020","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell proteomics reveal lesion-specific aberrant T cells and immunological profiles in mycosis fungoides","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}